Experimental infection of human volunteers with Haemophilus ducreyi does not confer protection against subsequent challenge

Jaffar A. Al-Tawfiq, Katherine L. Palmer, Cheng Yen Chen, Jennifer C. Haley, Barry P. Katz, Antoinette F. Hood, Stanley M. Spinola

Research output: Contribution to journalArticle

34 Scopus citations

Abstract

Two groups of human volunteers were inoculated with 2 doses of live Haemophilus ducreyi 35000HP. The reinfection group consisted of 7 subjects who previously had participated in experimental infection with 35000HP to the pustular stage of disease. The control group consisted of 7 naive subjects. Papules developed at 92.8% (95% confidence interval [CI], 66.1%-99.8%) of sites inoculated with live bacteria, in the reinfection group, and at 85.7% (95% CI, 57.2%-98.2%) of sites in the control group. Sixty-nine percent (95% CI, 36.8%-90.9%) of papules evolved into pustules in the reinfection group, compared with 41% (95% CI, 15.2%-72.3%) in the control group. The recovery rates of H. ducreyi from surface cultures and the histopathology of biopsies obtained from both groups were similar. Thus, experimental infection to the pustular stage of disease does not provide protective immunity against subsequent challenge.

Original languageEnglish (US)
Pages (from-to)1283-1287
Number of pages5
JournalJournal of Infectious Diseases
Volume179
Issue number5
DOIs
StatePublished - May 5 1999

    Fingerprint

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this